UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000006411
Receipt No. R000007471
Official scientific title of the study Intralesional Cidofovir application in recurrent laryngeal papillomatosis
Date of disclosure of the study information 2011/10/04
Last modified on 2017/09/20 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Intralesional Cidofovir application in recurrent laryngeal papillomatosis
Title of the study (Brief title) Intralesional Cidofovir application in laryngeal papillomatosis
Region
Japan

Condition
Condition laryngeal papillomatosis
Classification by specialty
Oto-rhino-laryngology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 to determine the efficacy of intralesional injection of cidofovir in improving resolution of recurrent respiratory papillomatosis
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes to determine of frequency of relapses, and size.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria recurrent laryngeal papillma
Key exclusion criteria non recurrent laryngeal papillma
Target sample size 1

Research contact person
Name of lead principal investigator Eiji Yumoto
Organization Kumamoto university
Division name Otolaryngology Head & Neck Suregry
Address 1-1-1 Honjyo, Kumamoto
TEL 096-373-7076
Email jibika-ikyoku@kuh.kumamoto-u.ac.jp

Public contact
Name of contact person Tetsuji Sanuki
Organization Kumamoto university
Division name Otolaryngology Head & Neck Suregry
Address 1-1-1 Honjyo, Kumamoto
TEL 096-373-7076
Homepage URL
Email otostl0319@kuh.kumamoto-u.ac.jp

Sponsor
Institute Kumamoto university
Institute
Department

Funding Source
Organization non
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 熊本大学病院

Other administrative information
Date of disclosure of the study information
2011 Year 10 Month 04 Day

Progress
Recruitment status Completed
Date of protocol fixation
2011 Year 09 Month 04 Day
Anticipated trial start date
2011 Year 10 Month 01 Day
Last follow-up date
2016 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information observe drug response

Management information
Registered date
2011 Year 09 Month 27 Day
Last modified on
2017 Year 09 Month 20 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007471